PTCL, NOS: An update on classification, risk-stratification, and treatment

Overview of attention for article published in Frontiers in oncology, February 2023

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (72nd percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

So far, Altmetric has seen 9 X posts from 8 X users, with an upper bound of 9,671 followers.

RT @Lymphoma_Papers: PTCL, NOS: An update on classification, risk-stratification, and treatment #lymphoma #lymsm https://t.co/MFbcxbfmxC

RT @Lymphoma_Papers: PTCL, NOS: An update on classification, risk-stratification, and treatment #lymphoma #lymsm https://t.co/MFbcxbfmxC

RT @Lymphoma_Papers: PTCL, NOS: An update on classification, risk-stratification, and treatment #lymphoma #lymsm https://t.co/MFbcxbfmxC

RT @Lymphoma_Papers: PTCL, NOS: An update on classification, risk-stratification, and treatment #lymphoma #lymsm https://t.co/MFbcxbfmxC

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.